Publications by authors named "Amelia Buffone"

Claim this Profile
O
Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.
Anna Coppa, Arianna Nicolussi, Sonia D'Inzeo, Carlo Capalbo, Francesca Belardinilli, Amelia Buffone

Cancer Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.
Andrea Prodosmo, Amelia Buffone, Manlio Mattioni, Agnese Barnabei, Agnese Persichetti

J Exp Clin Cancer Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.
Andrea Prodosmo, Amelia Buffone, Manlio Mattioni, Agnese Barnabei, Agnese Persichetti

J Exp Clin Cancer Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.
Francesca Belardinilli, Carlo Capalbo, Amelia Buffone, Marialaura Petroni, Valeria Colicchia

Clin Biochem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup.
Evelina Miele, Angela Mastronuzzi, Agnese Po, Andrea Carai, Vincenzo Alfano, Amelia Buffone

Biomark Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.
Anna Coppa, Amelia Buffone, Carlo Capalbo, Arianna Nicolussi, Sonia D'Inzeo

Breast Cancer Res Treat· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case report.
Carlo Capalbo, Paolo Marchetti, Anna Coppa, Antonella Calogero, Emanuela Anastasi, Amelia Buffone

Cancer Biol Ther· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.
Arianna Nicolussi, Sonia D'Inzeo, Gabriella Mincione, Amelia Buffone, Maria Carmela Di Marcantonio

Int J Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain.
Giuseppe Giannini, Carlo Capalbo, Laura Ottini, Amelia Buffone, Laura De Marchis

J Clin Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families.
Amelia Buffone, Carlo Capalbo, Enrico Ricevuto, Tina Sidoni, Laura Ottini

Breast Cancer Res Treat· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?
Carlo Capalbo, Amelia Buffone, Annarita Vestri, Enrico Ricevuto, Christian Rinaldi

J Clin Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giuseppe Giannini, Carlo Capalbo, Elisabetta Ristori, Enrico Ricevuto, Tina Sidoni, Amelia Buffone

Breast Cancer Res Treat· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software.
Carlo Capalbo, Enrico Ricevuto, Annarita Vestri, Tina Sidoni, Amelia Buffone

Eur J Hum Genet· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis